Key Takeaways Innovation in fund offerings and strategic partnerships are driving diversification, supporting long-term growth, recurring income, and enhanced profitability. Strong demand for alternatives, mid-market expertise, and digital focus position Bridgepoint for robust earnings and increased investor appeal.Read more
Bridgepoint Group plc is a private equity and private credit firm specializing in middle market, lower mid-market, small mid cap, small cap, growth capital, buyouts investments, syndicate debt, infrastructure, direct lending and credit opportunities in private credit investments. It prefers to invest in advanced industrials, automation, agricultural sciences, energy transition enablers, business services, financial services, professional services, testing inspection and certification, information services, consumer, digital brands, video games, wellbeing products, health care, pharma and Med-Tech outsourced services, pharma products, and Med-Tech Products sectors. The firm prefers to invest in companies based in United Kingdom, New York and Nordic region. It prefers to makes equity investment between £4.77 million ($5.91 million) and £125 million ($154.82 million), for small mid cap between £40 million ($49.54 million) and £125 million ($154.82 million) and for small cap between £10 million ($12.39 million) and £25 million ($30.96 million), with enterprise value between €10 million ($10.74 million) and €1000 million ($1073.62 million). Bridgepoint Group plc was founded in 1985 and is based in London, United Kingdom with additional offices in North America, Asia and Europe. Bridgepoint Group plc formerly known as Bridgepoint Group Limited.
